Sign in
Taking peoplePhase 2

L-Carnitine for Wound Healing in People With Diabetic Foot Ulcer

Tests L-carnitine supplements on ulcer size in people with diabetic foot ulcer.

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
The Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer.
Status
Recruiting
Phase
Phase 2
People taking part
50 people, planned
Started
1 Sept 2026
Expected to end
1 Aug 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • L- carnitine
Record updated
17 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with diabetes, nerve damage from diabetes and a mild to moderate diabetic foot ulcer. It tests L-Carnitine added to standard care.

Age
30 to 75 years
Sex
Men and women
Disease stage
Diabetic foot ulcer grade 1-2 (mild to moderate) on the Wagner scale, with diabetic neuropathy (nerve damage). Diabetes for 5 - 10 years.
Earlier treatment
People must take a stable dose of diabetes medicine before and during the study. No antioxidant supplements (vitamin E, ascorbic acid, omega 3 fatty acid, Coenzyme Q10) in the three months before joining.
Biomarker or test result
HbA1c (a blood test of long-term sugar levels) < 9.

Main reasons for not taking part

  • Ulcers from other causes
  • Autoimmune disease
  • Liver disease or kidney disease
  • Taking medicines for cancer
  • Thyroid disease

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adult Male or Female patients with diabetic neuropathy mean age (30-75) years old
  • Having Diabetic neuropathy and Diabetic foot ulcer grade 1-2 (mild- moderate) according to Wagner classification
  • Uncontrolled diabetic patients (HbA1c). < 9 duration of diabetic (5 - 10) years
  • All patient treated with stable dose of anti-diabetic medication priors and during the period of the study

Who cannot take part

  • Patient taking any antioxidant supplements including vitamin E, ascorbic acid, omega 3 fatty acid, Coenzyme Q10 within three months prior to enrollment in the study
  • Patient with autoimmune disease
  • Patient with liver disease or kidney disease
  • Patient taking medications for cancer
  • Patient with thyroid disease
  • Patients with other causes of ulcers

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Primary outcome: To evaluate the efficacy of L-Carnitine supplementation on length and depth ulcer size

Read full original descriptionShow less

Secondary outcome: To investigate the effect of L-Carnitine supplements on:

1. Vascular endothelial growth factor (VEGF) 2. Inflammatory markers TNF-a (Tumor necrosis factor alpha). 3. Hemoglobin A1C (HbA1c) And Lipid profile (cholesterol, triglycerides, high-density Lipoprotein (HDL) and low-density lipoprotein (LDL)). 4. To assess the type and likelihood of any adverse drug reaction that can be related to L-Carnitine supplementation. 5. QOL (DIABETES 39)

The 2 groups in the trial

  • TreatmentTreatment being tested

    To receive oral L-carnitine plus standard care therapy

    Treatment: L- carnitine

  • ControlNo study treatment, for comparison

    To receive only standard of care therapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer.
Plain-language title
L-Carnitine for Wound Healing in People With Diabetic Foot UlcerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07768228, who can take part
Record updated
17 August 2026